Clinical TrialID 8006

Prevention of Post-OP AFib Using Combination of CardiaMend and Amiodarone

NCT05681182

Post Operative Atrial Fibrillation

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
8006
Evidence Id
8006
Core Evidence Id
8006
Source Clinical Trial Id
8001
Herb2 Clinical Trial Id
HBCT008001
Nct Id
NCT05681182
Title
Prevention of Post-OP AFib Using Combination of CardiaMend and Amiodarone
Status
Completed
Phase
Phase 4
Study Result
No
Study Condition
Post Operative Atrial Fibrillation
Study Type
Interventional
Study Design
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
Intervention
COMBINATION_PRODUCT: CardiaMend with the Addition of Amiodarone
Intervention Allocation
Intervention Model
Single_Group
Intervention Mask
Intervention Purpose
Prevention
Gender
All
Age
Adult, Older_Adult
Enrollment
30
Outcome Measure
Post Operative Atrial Fibrillation, The patient have continuous ECG monitoring until discharge to evaluate for any evidence of atrial fibrillation or atrial flutter which lasts longer than one hour or if less than one hour, requires medical or procedural intervention, Through discharge, an average of 2 weeks
Sponsor Collaborator
WakeMed Health and Hospitals|Helios Cardio Inc
Funded By
OTHER
Location
WakeMed Health and Hospitals, Raleigh, North Carolina, 27610, United States
Other Id
1937514
Start Date
2023-01-20
Primary Completion Date
2024-02-06
Completion Date
2024-02-06
First Posted
2023-01-12
Results First Posted
Last Update Posted
2024-02-22
Study Document
Study Url
https://clinicaltrials.gov/study/NCT05681182
Title Cn
Title En
Prevention of Post-OP AFib Using Combination of CardiaMend and Amiodarone
Bilingual Status
semi_complete